Omega Fund Management

Latest statistics and disclosures from Omega Fund Management's latest quarterly 13F-HR filing:

Companies in the Omega Fund Management portfolio as of June 2019 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Gossamer Bio Inc 39.34 6.95M 22.18
Replimune Group Inc 19.02 5.10M 14.61
Morphic Hldg Inc Com 15.01 2.97M NEW 19.82
Translate Bio Inc 7.85 2.44M 12.63
Immunic Inc 4.01 1.37M NEW 11.47
Obseva Sa 2.88 999364 11.31
Paratek Pharmaceuticals 2.65 2.60M 3.99
Trevi Therapeutics Inc 2.42 1.26M NEW 7.50
Prevail Therapeutics Ord 2.25 668908 NEW 13.20
Fibrogen 1.51 130646 45.18
Pieris Pharmaceuticals 0.90 754457 -3% 4.70
Essa Pharma Inc 0.68 1.08M 2.45
Jounce Therapeutics 0.67 529965 4.95
Cidara Therapeutics Inc Common Stock Usd 0.0001 0.65 1.51M 1.68
Sienna Biopharmaceuticals Inc 0.17 758610 0.87

Past 13F-HR SEC Filings by Omega Fund Management

View All Filings